In hematological malignancies, AP-1 components are involved in CML and AML (83–85), and play important roles in the pathogeneses of lymphomas, HD, and ALCL (86, 87). This evidence concerns the gene FOS and chronic myelogenous leukemia, BCR-ABL1 positive.